Related Experiment Video
Updated: Oct 8, 2026

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
Effectiveness of cardiac transplantation for primary (AL) cardiac amyloidosis
F Pelosi1, J Capehart, W C Roberts
1Department of Medicine, Baylor University Medical Center, Dallas, Texas 75246, USA.
Insights
Cardiac amyloidosis caused severe heart dysfunction. Cardiac transplantation offered extended survival in this patient and another similar case, suggesting its potential as a treatment for cardiac amyloidosis.
Area of Science:
- Cardiology
- Pathology
- Transplantation
Background:
- Amyloidosis can lead to severe cardiac dysfunction due to amyloid deposition.
- Intramural coronary artery involvement is a critical factor in cardiac amyloidosis.
- Limited treatment options exist for advanced cardiac amyloidosis.
Abstract:
A patient is described in whom severe cardiac dysfunction developed from amyloid deposited entirely in the walls and lumens of intramural coronary arteries, underwent cardiac transplantation, survived another 69 months, died suddenly, and at necropsy had amyloid again limited to the walls and lumens of the intramyocardial coronary arteries in the donor heart. The rather lengthy survival in this patient and the 118-month survival in a similar previously reported patient suggests that cardiac transplantation may be an appropriate procedure for some patients with cardiac amyloidosis.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

